HKTVmall:同一批次口罩測試結果與消委會有出入 成人口罩售價應為65元30片
消委會發表針對口罩評測的報告指,香港電視(01137.HK)旗下HKTVmall口罩在合成血穿透測試中,於80mm Hg的測試仍有2個樣本被合成血穿透,表現不理想,而耳帶亦容易拉斷。而針對報告指公司口罩售價約為100元10片,HKTVmall回應指公司的成人口罩的售價應為65元30片,面層物料為淺綠色,而合成血穿透測試的結果與公司於今年4月及11月透過SGS進行的測試有頗大出入。
公司指於4月時為32個樣本進行測試,當中31個樣本通過測試;而11月進行了共96個樣本測試,測試結果為當中89個均通過測試。以上述的口罩,均為消委會用作測試口罩的相同及同一批次物料,而此項測試一段以32個口罩為測試單位,當中29個樣本通過測試即為合格通過測試。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.